Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions

June 7, 2021
Sales and Marketing AstraZeneca, GSK, court

AstraZeneca has launched a court case against Glaxo Smith Kline (GSK), in a claim that could reach hundreds of millions …

News
az

AstraZeneca’s lung cancer drug gains EU approval

May 28, 2021
Medical Communications AstraZeneca, EU, lung cancer, oncology

AstraZeneca’s Tagrisso (osimertinib) has been approved in the EU for the adjuvant treatment of adult patients with early-stage (IB, II …

News
Amgen flag

AstraZeneca and Amgen asthma drug shows positive results in Phase III trial

May 13, 2021
Amgen, AstraZeneca, asthma, asthma treatment, pharma, pharma news, severe asthma

AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority across all primary and secondary …

News
az

AstraZeneca to collaborate with Alchemab on prostate cancer research

May 6, 2021
AstraZeneca, prostate cancer

AstraZeneca have announced a new collaboration with Cambridge-based biotech company Alchemab, with the aim of accelerating prostate cancer research. Alchemab …

News

AstraZeneca drug approved by FDA for kidney disease treatment

May 4, 2021
Manufacturing and Production AstraZeneca, FDA, kidney disease, pharma, pharma news

AstraZeneca’s Farxiga drug has been approved for the treatment of chronic kidney disease (CKD) in the US by the FDA.

News
EU building with flags outside it

European Commission sues AstraZeneca over COVID-19 jab supplies

April 27, 2021
Manufacturing and Production AstraZeneca, AstraZeneca vaccine, COVID-19, EU, European Commission, covid 19 news, covid-19 news, european union, pharma, pharma news

The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 …

News
sanofi_hq__boetie_hall_web

Sanofi’s RSV drug sees Phase III clinical trial success

April 26, 2021
Sales and Marketing AstraZeneca, Sanofi

Sanofi have announced positive topline results from the Phase III MELODY trial into nirsevimab, which demonstrated protection against respiratory syncytial …

News
az

AstraZeneca drug evaluated in nine eosinophilic diseases

April 23, 2021
Medical Communications AstraZeneca

AstraZeneca announced on Thursday that the first patients had been dosed in the Phase III Fasenra (benralizumab) clinical trial in …

News
credit_-_crevis_shutterstock_340710245_720

Enhertu now available via Cancer Drugs Fund following NICE decision

April 20, 2021
Manufacturing and Production AstraZeneca, breast cancer, oncology

AstraZeneca and Daiichi Sankyo have announced that NICE has approved Enhertu (trastuzumab deruxtecan) for use within the Cancer Drugs Fund …

News
az

Forxiga accepted for use within NHS Scotland for chronic heart failure

April 14, 2021
Research and Development AstraZeneca, nhs scotland

AstraZeneca have announced that Forxiga (dapagliflozin) has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) …

News
AstraZeneca sign

AstraZeneca’s Farxiga falls short in Phase III trials for treatment of COVID-19

April 13, 2021
Manufacturing and Production AstraZeneca, COVID-19, covid-19 treatment, farxiga, pharma, pharma news

AstraZeneca’s Farxiga drug, usually used in patients with diabetes, did not show statistical significance in the Phase III trial into …

News
astrazeneca_sign_sky

AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe

April 7, 2021
Research and Development AstraZeneca, COVID-19, Vaccine

AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …

News
AstraZeneca sign

AstraZeneca vaccine found to be 3% less effective after further trial analysis

March 25, 2021
AstraZeneca, AstraZeneca vaccine, COVID-19, COVID-19 vaccine, Vaccine

AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms …

News

AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA

March 19, 2021
Medical Communications AstraZeneca, COVID-19, EMA, Vaccine

AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …

News

AstraZeneca & MSD ovarian cancer drug combination approved by NICE

March 19, 2021
Medical Communications AstraZeneca, MSD, NICE, oncology

A new precision drug combination, olaparib with bevacizumab, will now be available on the Cancer Drugs Fund (CDF) for ovarian …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025